Research letter: Evaluating the future pathological N descriptors for lung cancer staging in a UK population

Lung Cancer. 2017 Jul:109:149-151. doi: 10.1016/j.lungcan.2017.04.008. Epub 2017 Apr 15.

Authors

Tim Edwards¹, Haval Balata¹, Philip Foden², Philip Crosbie¹, Richard Booton¹, Matthew Evison³

Affiliations

¹ Manchester Thoracic Oncology Centre, University Hospital South Manchester, Southmoor Road, Manchester M23 9LT, UK.
² Department of Medical Statistics, University Hospital South Manchester, Southmoor Road, Manchester M23 9LT, UK.
³ Manchester Thoracic Oncology Centre, University Hospital South Manchester, Southmoor Road, Manchester M23 9LT, UK. Electronic address: matthew.evison@uhsm.nhs.uk.

PMID: 28442146
DOI: 10.1016/j.lungcan.2017.04.008

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Non-Small-Cell Lung / diagnosis
Carcinoma, Non-Small-Cell Lung / epidemiology
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms / diagnosis*
Lung Neoplasms / epidemiology
Male
Neoplasm Staging* / methods
Prognosis
United Kingdom / epidemiology